Remedium Lifecare Limited (BOM:539561)
India flag India · Delayed Price · Currency is INR
1.820
+0.030 (1.68%)
At close: Apr 28, 2025

Remedium Lifecare Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Net Income
327.354.2610.784.812.77
Upgrade
Depreciation & Amortization
0.571.510.740.60.13
Upgrade
Other Operating Activities
36.910.31.061.350.99
Upgrade
Change in Accounts Receivable
-7,478-1,084-403.12-221.85-13.63
Upgrade
Change in Inventory
-1,259765.52-807.65-24.07-4.97
Upgrade
Change in Accounts Payable
6,271-403.451,008233.850.34
Upgrade
Change in Other Net Operating Assets
1,360870.64303.11-96.8212.39
Upgrade
Operating Cash Flow
-741.61205112.83-102.13-1.97
Upgrade
Operating Cash Flow Growth
-81.69%---
Upgrade
Capital Expenditures
--0.43-0.5-0.39-2.44
Upgrade
Other Investing Activities
0.94----
Upgrade
Investing Cash Flow
0.94-0.43-0.5-0.39-2.44
Upgrade
Short-Term Debt Issued
577.03----
Upgrade
Long-Term Debt Issued
---101.372.88
Upgrade
Total Debt Issued
577.03--101.372.88
Upgrade
Long-Term Debt Repaid
---105.01--
Upgrade
Net Debt Issued (Repaid)
577.03--105.01101.372.88
Upgrade
Other Financing Activities
-38.73-0.37-1.07--
Upgrade
Financing Cash Flow
538.29-0.37-106.08101.372.88
Upgrade
Miscellaneous Cash Flow Adjustments
-0.94---0-0
Upgrade
Net Cash Flow
-203.32204.26.25-1.14-1.54
Upgrade
Free Cash Flow
-741.61204.57112.33-102.51-4.42
Upgrade
Free Cash Flow Growth
-82.12%---
Upgrade
Free Cash Flow Margin
-1.84%4.01%2.23%-11.39%-15.28%
Upgrade
Free Cash Flow Per Share
-1.840.510.28-0.25-0.01
Upgrade
Cash Interest Paid
38.730.37---
Upgrade
Cash Income Tax Paid
178.1219.774.480.380.01
Upgrade
Levered Free Cash Flow
-922.25190.6110.69-103.49-4.94
Upgrade
Unlevered Free Cash Flow
-897.1191.05111.13-103.42-4.9
Upgrade
Change in Net Working Capital
1,106-148.93-100.25107.764.92
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.